Shenyang Xingqi Pharmaceutical Co Ltd (300573) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.145x

Based on the latest financial reports, Shenyang Xingqi Pharmaceutical Co Ltd (300573) has a cash flow conversion efficiency ratio of 0.145x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥268.97 Million ≈ $39.36 Million USD) by net assets (CN¥1.86 Billion ≈ $271.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shenyang Xingqi Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Shenyang Xingqi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Shenyang Xingqi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shenyang Xingqi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shenyang Xingqi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX	-0.073x
Yapp Automotive Systems Co Ltd SHG:603013	0.242x
Jiangsu Chengxing Phosph-Chemical Co Ltd SHG:600078	0.150x
Sk Gas KO:018670	0.070x
Centuria Capital Group AU:CNI	0.019x
Laobaixing Pharmacy SHG:603883	0.074x
Anhui Estone Materials Technology Co Ltd SHG:688733	-0.014x
OC OERL.CORP ADR 2 SF 1 F:OBH0	N/A

Annual Cash Flow Conversion Efficiency for Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Shenyang Xingqi Pharmaceutical Co Ltd (300573) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.59 Billion ≈ $233.13 Million	CN¥416.98 Million ≈ $61.02 Million	0.262x	+39.28%
2023-12-31	CN¥1.69 Billion ≈ $247.29 Million	CN¥317.57 Million ≈ $46.47 Million	0.188x	+1.90%
2022-12-31	CN¥1.55 Billion ≈ $227.15 Million	CN¥286.26 Million ≈ $41.89 Million	0.184x	-19.23%
2021-12-31	CN¥1.34 Billion ≈ $196.74 Million	CN¥306.96 Million ≈ $44.92 Million	0.228x	+29.72%
2020-12-31	CN¥694.06 Million ≈ $101.56 Million	CN¥122.16 Million ≈ $17.88 Million	0.176x	+36.59%
2019-12-31	CN¥574.90 Million ≈ $84.13 Million	CN¥74.08 Million ≈ $10.84 Million	0.129x	+62.38%
2018-12-31	CN¥554.58 Million ≈ $81.15 Million	CN¥44.01 Million ≈ $6.44 Million	0.079x	+34.31%
2017-12-31	CN¥553.38 Million ≈ $80.98 Million	CN¥32.70 Million ≈ $4.78 Million	0.059x	+9.45%
2016-12-31	CN¥520.95 Million ≈ $76.23 Million	CN¥28.12 Million ≈ $4.12 Million	0.054x	-1.82%
2015-12-31	CN¥389.79 Million ≈ $57.04 Million	CN¥21.43 Million ≈ $3.14 Million	0.055x	+55.59%
2014-12-31	CN¥367.81 Million ≈ $53.82 Million	CN¥13.00 Million ≈ $1.90 Million	0.035x	+41.72%
2013-12-31	CN¥336.80 Million ≈ $49.28 Million	CN¥8.40 Million ≈ $1.23 Million	0.025x	-82.72%
2012-12-31	CN¥290.70 Million ≈ $42.54 Million	CN¥41.96 Million ≈ $6.14 Million	0.144x	+45.29%
2011-12-31	CN¥247.00 Million ≈ $36.14 Million	CN¥24.54 Million ≈ $3.59 Million	0.099x	--

About Shenyang Xingqi Pharmaceutical Co Ltd

SHE:300573 China Medical Instruments & Supplies

Market Cap

$1.31 Billion

CN¥8.98 Billion CNY

Market Cap Rank

#7907 Global

#1886 in China

Share Price

CN¥36.44

Change (1 day)

-1.01%

52-Week Range

CN¥35.40 - CN¥83.32

All Time High

CN¥204.82